BRCA Exchange combines information from major public sources to offer a comprehensive view of BRCA variants from a single web portal. It combines variant information from ClinVar, ENIGMA (as the ClinGen expert panel on BRCA variation) and LOVD (blue); population frequency data from 1000 Genomes, ExAC, and the ESP (red); and BRCA-specific information from the BIC on BRCA 1 and 2 Ex-UV (green). Each month, BRCA Exchange collects variant data from these sources and translates them into a consistent representation. It verifies that all variants are consistent in the reference bases with the reference human genome and discards any variant data that are inconsistent with the genome. Next, it identifies functionally equivalent variants, in which t...
<p>PCR-based RNA splicing assays are commonly used in diagnostic and research settings to assess the...
<p>PCR-based RNA splicing assays are commonly used in diagnostic and research settings to assess the...
<p>VCF files describing the mutations contained in the sixty-seven groups of BRCA1 reads. These were...
The BRCA Challenge is a long-term data-sharing project initiated within the Global Alliance for Geno...
The BRCA Challenge is a long-term data-sharing project initiated within the Global Alliance for Geno...
The BRCA Challenge is a long-term data-sharing project initiated within the Global Alliance for Geno...
International audienceAs next-generation sequencing increases access to human genetic variation, the...
Genetic tests of the cancer predisposition genes BRCA1 and BRCA2 inform significant clinical decisio...
As genetic testing for predisposition to human diseases has become an increasingly common practice i...
As genetic testing for predisposition to human diseases has become an increasingly common practice i...
<p>PCR-based RNA splicing assays are commonly used in diagnostic and research settings to assess the...
<p>PCR-based RNA splicing assays are commonly used in diagnostic and research settings to assess the...
<p>PCR-based RNA splicing assays are commonly used in diagnostic and research settings to assess the...
As genetic testing for predisposition to human diseases has become an increasingly common practice i...
<p>PCR-based RNA splicing assays are commonly used in diagnostic and research settings to assess the...
<p>PCR-based RNA splicing assays are commonly used in diagnostic and research settings to assess the...
<p>PCR-based RNA splicing assays are commonly used in diagnostic and research settings to assess the...
<p>VCF files describing the mutations contained in the sixty-seven groups of BRCA1 reads. These were...
The BRCA Challenge is a long-term data-sharing project initiated within the Global Alliance for Geno...
The BRCA Challenge is a long-term data-sharing project initiated within the Global Alliance for Geno...
The BRCA Challenge is a long-term data-sharing project initiated within the Global Alliance for Geno...
International audienceAs next-generation sequencing increases access to human genetic variation, the...
Genetic tests of the cancer predisposition genes BRCA1 and BRCA2 inform significant clinical decisio...
As genetic testing for predisposition to human diseases has become an increasingly common practice i...
As genetic testing for predisposition to human diseases has become an increasingly common practice i...
<p>PCR-based RNA splicing assays are commonly used in diagnostic and research settings to assess the...
<p>PCR-based RNA splicing assays are commonly used in diagnostic and research settings to assess the...
<p>PCR-based RNA splicing assays are commonly used in diagnostic and research settings to assess the...
As genetic testing for predisposition to human diseases has become an increasingly common practice i...
<p>PCR-based RNA splicing assays are commonly used in diagnostic and research settings to assess the...
<p>PCR-based RNA splicing assays are commonly used in diagnostic and research settings to assess the...
<p>PCR-based RNA splicing assays are commonly used in diagnostic and research settings to assess the...
<p>VCF files describing the mutations contained in the sixty-seven groups of BRCA1 reads. These were...